Oops! This Content is Members Only

Recent Content

• The influencing factors of renal response in newly diagnosed multiple myeloma patients with renal impairment
• Efficacy and safety of autologous hematopoietic stem cell transplantation pretreated with Melphalan hydrochloride for injection in the treatment of 125 cases of multiple myeloma
• Dr Deol on the Current Limitations of CAR T-cell Therapy in R/R Myeloma
• CT-defined body composition as a prognostic factor in multiple myeloma
• MRD Testing Made a Myeloma Survivor Feel ‘OK to Be Safe’
• CAR T-Cell Therapy for Multiple Myeloma: Eliminating Disparities Through Accountability
• Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
• Different Translocations of Multiple Myeloma on Fluorescent <em>In Situ</em> Hybridization (FISH) with Clinical Correlation
• Clinical evidence for immune-based strategies in early-line multiple myeloma: current challenges in decision-making for subsequent therapy
• Isatuximab in multiple myeloma